» Articles » PMID: 31825653

The FLASH Effect Depends on Oxygen Concentration

Overview
Journal Br J Radiol
Specialty Radiology
Date 2019 Dec 12
PMID 31825653
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recent results have shown prominent tissue sparing effect of radiotherapy with ultra-high dose rates (FLASH) compared to conventional dose rates (CONV). Oxygen depletion has been proposed as the underlying mechanism, but data to support this have been lacking. The aim of the current study was to compare FLASH to CONV irradiation under different oxygen concentrations .

Methods: Prostate cancer cells were irradiated at different oxygen concentrations (relative partial pressure ranging between 1.6 and 20%) with a 10 MeV electron beam at a dose rate of either 600 Gy/s (FLASH) or 14 Gy/min (CONV), using a modified clinical linear accelerator. We evaluated the surviving fraction of cells using clonogenic assays after irradiation with doses ranging from 0 to 25 Gy.

Results: Under normoxic conditions, no differences between FLASH and CONV irradiation were found. For hypoxic cells (1.6%), the radiation response was similar up to a dose of about 5-10 Gy, above which increased survival was shown for FLASH compared to CONV irradiation. The increased survival was shown to be significant at 18 Gy, and the effect was shown to depend on oxygen concentration.

Conclusion: The FLASH effect depends on oxygen concentration. Further studies to characterize and optimize the use of FLASH in order to widen the therapeutic window are indicated.

Advances In Knowledge: This paper shows evidence for the role of oxygen concentration underlying the difference between FLASH and CONV irradiation.

Citing Articles

FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.

Ni H, Reitman Z, Zou W, Akhtar M, Paul R, Huang M Nat Cancer. 2025; .

PMID: 39910249 DOI: 10.1038/s43018-025-00905-6.


Ultra‑high dose rate (FLASH) treatment: A novel radiotherapy modality (Review).

Huang J, Cheng J, Shi B, Du X, Tang S, Lin B Mol Clin Oncol. 2025; 22(3):23.

PMID: 39885864 PMC: 11775888. DOI: 10.3892/mco.2025.2818.


A 2D detector array for relative dosimetry and beam steering for FLASH radiotherapy with electrons.

Schonfeld A, Hildreth J, Bourgouin A, Flatten V, Kozelka J, Simon W Med Phys. 2024; 52(3):1845-1857.

PMID: 39688375 PMC: 11880641. DOI: 10.1002/mp.17573.


FLASH Radiotherapy: Benefits, Mechanisms, and Obstacles to Its Clinical Application.

Alhaddad L, Osipov A, Leonov S Int J Mol Sci. 2024; 25(23).

PMID: 39684218 PMC: 11641130. DOI: 10.3390/ijms252312506.


A High-Throughput Neurosphere-Based Colony Formation Assay to Test Drug and Radiation Sensitivity of Different Patient-Derived Glioblastoma Lines.

Kumar M, Nassour-Caswell L, Alrefai H, Anderson J, Schanel T, Hicks P Cells. 2024; 13(23).

PMID: 39682742 PMC: 11640616. DOI: 10.3390/cells13231995.


References
1.
McMahon S . The linear quadratic model: usage, interpretation and challenges. Phys Med Biol. 2018; 64(1):01TR01. DOI: 10.1088/1361-6560/aaf26a. View

2.
Berry R, Hall E, Forster D, Storr T, GOODMAN M . Survival of mammalian cells exposed to x rays at ultra-high dose-rates. Br J Radiol. 1969; 42(494):102-7. DOI: 10.1259/0007-1285-42-494-102. View

3.
Bourhis J, Montay-Gruel P, Goncalves Jorge P, Bailat C, Petit B, Ollivier J . Clinical translation of FLASH radiotherapy: Why and how?. Radiother Oncol. 2019; 139:11-17. DOI: 10.1016/j.radonc.2019.04.008. View

4.
Town C . Radiobiology. Effect of high dose rates on survival of mammalian cells. Nature. 1967; 215(5103):847-8. DOI: 10.1038/215847a0. View

5.
Symonds P, Jones G . FLASH Radiotherapy: The Next Technological Advance in Radiation Therapy?. Clin Oncol (R Coll Radiol). 2019; 31(7):405-406. DOI: 10.1016/j.clon.2019.05.011. View